CorMedix, Inc.
(NYSE Amex Equities : CRMD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories 0.00%79.440.8%$1114.36m
MDTMedtronic Plc 0.16%86.290.6%$860.45m
TMOThermo Fisher Scientific, Inc. -1.96%281.911.0%$841.62m
DHRDanaher Corp. -0.89%135.210.7%$679.29m
ISRGIntuitive Surgical, Inc. -1.12%462.472.4%$662.82m
BDXBecton, Dickinson & Co. -2.82%226.711.1%$646.44m
SYKStryker Corp. -0.95%148.161.3%$525.27m
BSXBoston Scientific Corp. 0.39%31.171.1%$482.24m
EWEdwards Lifesciences Corp. 2.26%189.041.2%$418.36m
DXCMDexCom, Inc. -2.11%260.758.2%$379.18m
INOInovio Pharmaceuticals, Inc. 2.93%7.746.8%$370.82m
BAXBaxter International, Inc. -0.96%81.431.8%$369.54m
ZBHZimmer Biomet Holdings, Inc. -0.81%91.961.7%$249.09m
IDXXIDEXX Laboratories, Inc. -2.15%234.553.8%$243.02m
ALGNAlign Technology, Inc. 1.40%154.206.4%$226.49m

Company Profile

CorMedix, Inc. operates as a pharmaceutical and medical device company. The firm seeks to license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ.